Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Screening Shortfalls and Self-Collected Samples
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Advancements in Antimicrobial Susceptibility Testing: Part 2
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
Comprehensive Coding
Understanding the 2024 CLFS update—and the changes that are still to come.
Billing and Coding: The Value of Clinical Validation
What clinical validation really means—and why every member of the laboratory should understand it.
Can Conducting a Billing Audit Increase My Lab’s Revenue Stream?
Audits can be helpful not just for compliance purposes, but for maximizing reimbursement and maintaining a healthy business.
A Primer for New Lab Sales Managers
Join us and our expert to review important components a sales manager should consider in helping their staff be prepared, professional, and productive.
Expert Q&A: Lab and Pathology Industry 2023 Year in Review
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Year in Review: The 8 Most Important Lab Compliance Stories of 2023
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
FDA Watch: Key Lab Test Clearances of 2023
G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.